nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—ACSL3—forebrain—attention deficit hyperactivity disorder	0.0366	0.0654	CbGeAlD
Icosapent—ACSL3—cardiovascular system—attention deficit hyperactivity disorder	0.031	0.0553	CbGeAlD
Icosapent—SLC8A1—forebrain—attention deficit hyperactivity disorder	0.0304	0.0542	CbGeAlD
Icosapent—SLC8A1—cardiovascular system—attention deficit hyperactivity disorder	0.0257	0.0458	CbGeAlD
Icosapent—FABP7—forebrain—attention deficit hyperactivity disorder	0.0223	0.0399	CbGeAlD
Icosapent—ACSL3—nervous system—attention deficit hyperactivity disorder	0.0199	0.0355	CbGeAlD
Icosapent—ACSL3—central nervous system—attention deficit hyperactivity disorder	0.0191	0.0342	CbGeAlD
Icosapent—ACSL4—forebrain—attention deficit hyperactivity disorder	0.0184	0.0328	CbGeAlD
Icosapent—SLC8A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0181	0.0412	CbGpPWpGaD
Icosapent—PPARD—forebrain—attention deficit hyperactivity disorder	0.0177	0.0315	CbGeAlD
Icosapent—SLC8A1—nervous system—attention deficit hyperactivity disorder	0.0165	0.0294	CbGeAlD
Icosapent—FFAR1—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.0164	0.0374	CbGpPWpGaD
Icosapent—SLC8A1—central nervous system—attention deficit hyperactivity disorder	0.0159	0.0283	CbGeAlD
Icosapent—ACSL4—cardiovascular system—attention deficit hyperactivity disorder	0.0156	0.0278	CbGeAlD
Icosapent—ACSL3—brain—attention deficit hyperactivity disorder	0.0152	0.0271	CbGeAlD
Icosapent—FADS1—midbrain—attention deficit hyperactivity disorder	0.0134	0.0239	CbGeAlD
Icosapent—FFAR1—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0129	0.0294	CbGpPWpGaD
Icosapent—SLC8A1—brain—attention deficit hyperactivity disorder	0.0126	0.0225	CbGeAlD
Icosapent—ACSL4—midbrain—attention deficit hyperactivity disorder	0.0121	0.0217	CbGeAlD
Icosapent—FABP7—nervous system—attention deficit hyperactivity disorder	0.0121	0.0216	CbGeAlD
Icosapent—FABP7—central nervous system—attention deficit hyperactivity disorder	0.0117	0.0208	CbGeAlD
Icosapent—PPARD—midbrain—attention deficit hyperactivity disorder	0.0117	0.0208	CbGeAlD
Icosapent—FABP7—cerebellum—attention deficit hyperactivity disorder	0.0114	0.0204	CbGeAlD
Icosapent—FFAR1—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.0113	0.0258	CbGpPWpGaD
Icosapent—TRPV1—nervous system—attention deficit hyperactivity disorder	0.011	0.0196	CbGeAlD
Icosapent—TRPV1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0109	0.0248	CbGpPWpGaD
Icosapent—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNB2—attention deficit hyperactivity disorder	0.0108	0.0246	CbGpPWpGaD
Icosapent—TRPV1—central nervous system—attention deficit hyperactivity disorder	0.0106	0.0189	CbGeAlD
Icosapent—FFAR1—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.0104	0.0236	CbGpPWpGaD
Icosapent—FADS1—cerebellum—attention deficit hyperactivity disorder	0.0103	0.0185	CbGeAlD
Icosapent—ACSL4—nervous system—attention deficit hyperactivity disorder	0.00998	0.0178	CbGeAlD
Icosapent—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—CACNA1C—attention deficit hyperactivity disorder	0.00989	0.0225	CbGpPWpGaD
Icosapent—ACSL4—central nervous system—attention deficit hyperactivity disorder	0.00961	0.0172	CbGeAlD
Icosapent—PPARD—nervous system—attention deficit hyperactivity disorder	0.00959	0.0171	CbGeAlD
Icosapent—ACSL4—cerebellum—attention deficit hyperactivity disorder	0.00939	0.0168	CbGeAlD
Icosapent—FABP7—brain—attention deficit hyperactivity disorder	0.00926	0.0165	CbGeAlD
Icosapent—PPARD—central nervous system—attention deficit hyperactivity disorder	0.00923	0.0165	CbGeAlD
Icosapent—FFAR1—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00907	0.0206	CbGpPWpGaD
Icosapent—PPARD—cerebellum—attention deficit hyperactivity disorder	0.00902	0.0161	CbGeAlD
Icosapent—FFAR1—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.00892	0.0203	CbGpPWpGaD
Icosapent—FFAR1—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00863	0.0196	CbGpPWpGaD
Icosapent—FADS1—brain—attention deficit hyperactivity disorder	0.0084	0.015	CbGeAlD
Icosapent—TRPV1—brain—attention deficit hyperactivity disorder	0.0084	0.015	CbGeAlD
Icosapent—PPARG—forebrain—attention deficit hyperactivity disorder	0.00827	0.0148	CbGeAlD
Icosapent—FFAR1—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00816	0.0185	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0081	0.0184	CbGpPWpGaD
Icosapent—ACSL4—brain—attention deficit hyperactivity disorder	0.00763	0.0136	CbGeAlD
Icosapent—PPARD—brain—attention deficit hyperactivity disorder	0.00733	0.0131	CbGeAlD
Icosapent—FFAR1—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00713	0.0162	CbGpPWpGaD
Icosapent—PPARG—cardiovascular system—attention deficit hyperactivity disorder	0.007	0.0125	CbGeAlD
Icosapent—FFAR1—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00679	0.0154	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00625	0.0142	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00612	0.0139	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00608	0.0138	CbGpPWpGaD
Icosapent—SLC8A1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00565	0.0128	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00535	0.0122	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00524	0.0119	CbGpPWpGaD
Icosapent—PPARG—nervous system—attention deficit hyperactivity disorder	0.00449	0.00802	CbGeAlD
Icosapent—PTGS1—forebrain—attention deficit hyperactivity disorder	0.00442	0.0079	CbGeAlD
Icosapent—PPARG—central nervous system—attention deficit hyperactivity disorder	0.00432	0.00772	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00424	0.00964	CbGpPWpGaD
Icosapent—PTGS2—forebrain—attention deficit hyperactivity disorder	0.00423	0.00755	CbGeAlD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00412	0.00936	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00408	0.00927	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00399	0.00908	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00397	0.00904	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00393	0.00893	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00379	0.00862	CbGpPWpGaD
Icosapent—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00374	0.00668	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00371	0.00843	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00363	0.00826	CbGpPWpGaD
Icosapent—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.00357	0.00638	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00345	0.00784	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00343	0.00781	CbGpPWpGaD
Icosapent—PPARG—brain—attention deficit hyperactivity disorder	0.00343	0.00613	CbGeAlD
Icosapent—SLC8A1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00336	0.00765	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00334	0.00759	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00328	0.00746	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00324	0.00737	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00318	0.00722	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00312	0.00709	CbGpPWpGaD
Icosapent—PPARD—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00306	0.00695	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00302	0.00686	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00295	0.00671	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00286	0.0065	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00282	0.00641	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00281	0.00639	CbGpPWpGaD
Icosapent—PTGS2—midbrain—attention deficit hyperactivity disorder	0.00279	0.00498	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00278	0.00631	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00277	0.00629	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00274	0.00622	CbGpPWpGaD
Icosapent—PPARD—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00272	0.00619	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00259	0.00588	CbGpPWpGaD
Icosapent—FADS1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.00245	0.00557	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00245	0.00556	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00242	0.0055	CbGpPWpGaD
Icosapent—PTGS1—nervous system—attention deficit hyperactivity disorder	0.0024	0.00429	CbGeAlD
Icosapent—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.0024	0.00545	CbGpPWpGaD
Icosapent—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00231	0.00413	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0023	0.00524	CbGpPWpGaD
Icosapent—PTGS2—nervous system—attention deficit hyperactivity disorder	0.0023	0.0041	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00226	0.00513	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00225	0.00511	CbGpPWpGaD
Icosapent—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.00221	0.00395	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00218	0.00495	CbGpPWpGaD
Icosapent—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.00216	0.00386	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00214	0.00487	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00211	0.00481	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00211	0.00481	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00209	0.00476	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00205	0.00466	CbGpPWpGaD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00197	0.00448	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00197	0.00448	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00195	0.00443	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00192	0.00435	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00184	0.00419	CbGpPWpGaD
Icosapent—PTGS1—brain—attention deficit hyperactivity disorder	0.00184	0.00328	CbGeAlD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00181	0.00412	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00177	0.00402	CbGpPWpGaD
Icosapent—PTGS2—brain—attention deficit hyperactivity disorder	0.00175	0.00313	CbGeAlD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00165	0.00376	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00371	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00162	0.00367	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00156	0.00356	CbGpPWpGaD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00149	0.0034	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.00336	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00148	0.00336	CbGpPWpGaD
Icosapent—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00145	0.0033	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00144	0.00327	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00143	0.00326	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00142	0.00323	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00138	0.00314	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00314	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00137	0.00311	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00135	0.00306	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00135	0.00306	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00132	0.00301	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—EP300—attention deficit hyperactivity disorder	0.00132	0.00301	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00129	0.00294	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00129	0.00294	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00127	0.00289	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00125	0.00284	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00124	0.00282	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.00281	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00123	0.0028	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00123	0.0028	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00121	0.00276	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00121	0.00275	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00121	0.00275	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.0012	0.00272	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00119	0.0027	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00115	0.00262	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00113	0.00257	CbGpPWpGaD
Icosapent—FADS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00113	0.00256	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00113	0.00256	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00112	0.00254	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00112	0.00254	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00111	0.00253	CbGpPWpGaD
Icosapent—FADS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00111	0.00252	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.0011	0.0025	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00109	0.00247	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00108	0.00245	CbGpPWpGaD
Icosapent—FADS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00103	0.00235	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00233	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00102	0.00233	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00102	0.00232	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00102	0.00232	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00102	0.00232	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00102	0.00232	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00101	0.0023	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.001	0.00228	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.001	0.00228	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—EP300—attention deficit hyperactivity disorder	0.000976	0.00222	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000942	0.00214	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000933	0.00212	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000933	0.00212	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—attention deficit hyperactivity disorder	0.000905	0.00206	CbGpPWpGaD
Icosapent—FADS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000902	0.00205	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000858	0.00195	CbGpPWpGaD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00084	0.00191	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000839	0.00191	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000831	0.00189	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000815	0.00185	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000815	0.00185	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000815	0.00185	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00081	0.00184	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.000799	0.00182	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000787	0.00179	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000785	0.00179	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00078	0.00177	CbGpPWpGaD
Icosapent—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000777	0.00177	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000776	0.00176	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000776	0.00176	CbGpPWpGaD
Icosapent—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000771	0.00175	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00076	0.00173	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000733	0.00167	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00072	0.00164	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000708	0.00161	CbGpPWpGaD
Icosapent—FADS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000683	0.00155	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000682	0.00155	CbGpPWpGaD
Icosapent—PPARG—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.00068	0.00155	CbGpPWpGaD
Icosapent—FADS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000679	0.00154	CbGpPWpGaD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000666	0.00151	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00066	0.0015	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000658	0.0015	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000649	0.00148	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000641	0.00146	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000618	0.0014	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000618	0.0014	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000614	0.0014	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000614	0.0014	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000603	0.00137	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000597	0.00136	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000595	0.00135	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000573	0.0013	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000573	0.0013	CbGpPWpGaD
Icosapent—PPARD—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000564	0.00128	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000543	0.00124	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000524	0.00119	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000514	0.00117	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000469	0.00107	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000459	0.00104	CbGpPWpGaD
Icosapent—PPARD—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000458	0.00104	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000454	0.00103	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000436	0.000992	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00042	0.000954	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000418	0.000951	CbGpPWpGaD
Icosapent—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.000351	0.000797	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—EP300—attention deficit hyperactivity disorder	0.00035	0.000795	CbGpPWpGaD
Icosapent—PPARD—Metabolism—COMT—attention deficit hyperactivity disorder	0.000347	0.00079	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000345	0.000784	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000334	0.00076	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000318	0.000722	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000313	0.000712	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000313	0.000712	CbGpPWpGaD
Icosapent—PPARG—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000308	0.0007	CbGpPWpGaD
Icosapent—FADS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000293	0.000666	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000286	0.000651	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000265	0.000602	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000265	0.000602	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000252	0.000573	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00025	0.000569	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000243	0.000553	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000238	0.000542	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000222	0.000504	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000219	0.000499	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000219	0.000499	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000216	0.00049	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000204	0.000465	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000201	0.000456	CbGpPWpGaD
Icosapent—PPARG—Metabolism—COMT—attention deficit hyperactivity disorder	0.00019	0.000431	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000188	0.000428	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000183	0.000415	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000175	0.000399	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000174	0.000396	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000174	0.000396	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000171	0.000389	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000167	0.000379	CbGpPWpGaD
Icosapent—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000166	0.000378	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000159	0.000362	CbGpPWpGaD
Icosapent—PPARD—Metabolism—EP300—attention deficit hyperactivity disorder	0.000149	0.000339	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000139	0.000316	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000133	0.000302	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000132	0.000301	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000132	0.0003	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000128	0.000291	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000105	0.00024	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000105	0.000238	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000102	0.000231	CbGpPWpGaD
Icosapent—PPARG—Metabolism—EP300—attention deficit hyperactivity disorder	8.13e-05	0.000185	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	5.7e-05	0.00013	CbGpPWpGaD
Icosapent—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	5.4e-05	0.000123	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	4.52e-05	0.000103	CbGpPWpGaD
